The New Medicine Service (NMS) provides support for people with long-term conditions newly prescribed a medicine to help improve medicines adherence; it is initially focused on particular patient groups and conditions.

The successful implementation of NMS will:

  • improve patient adherence which will generally lead to better health outcomes
  • increase patient engagement with their condition and medicines, supporting patients in making decisions about their treatment and self-management
  • reduce medicines wastage
  • reduce hospital admissions due to adverse events from medicines
  • lead to increased Yellow Card reporting of adverse reactions to medicines by pharmacists and patients, thereby supporting improved pharmacovigilance
  • receive positive assessment from patients
  • improve the evidence base on the effectiveness of the service